See more : The Planting Hope Company Inc. (MYLK.V) Income Statement Analysis – Financial Results
Complete financial analysis of Japan Tissue Engineering Co., Ltd. (7774.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Japan Tissue Engineering Co., Ltd., a leading company in the Biotechnology industry within the Healthcare sector.
- Exicom Tele-Systems Limited (EXICOM.NS) Income Statement Analysis – Financial Results
- Global Industrial Company (GIC) Income Statement Analysis – Financial Results
- IonQ, Inc. (IONQ) Income Statement Analysis – Financial Results
- Shanghai RAAS Blood Products Co., Ltd. (002252.SZ) Income Statement Analysis – Financial Results
- BKV Industries Limited (BKV.BO) Income Statement Analysis – Financial Results
Japan Tissue Engineering Co., Ltd. (7774.T)
About Japan Tissue Engineering Co., Ltd.
Japan Tissue Engineering Co., Ltd. engages in the regenerative medicine business in Japan. The company operates through Regenerative Medicine Product, Regenerative Medicine Outsourcing, and Research and Development Support segments. It offers autologous cultured epidermis, cartilage, corneal epithelium, and oral mucosal epithelium to medical institutions for the purpose of medical treatment. The company also provides tissue-engineered medical products. In addition, it researches and develops human 3-dimensional cultured tissue models for use in the development of cosmetics and drugs for external use, as well as in research that employs skin and cornea tissues. Further, the company offers regenerative medicine contract development and manufacturing services. The company was founded in 1999 and is headquartered in Gamagori, Japan. Japan Tissue Engineering Co., Ltd. is a subsidiary of Teijin Limited.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.51B | 2.03B | 2.10B | 2.26B | 2.31B | 2.36B | 2.27B | 2.14B | 1.43B | 1.32B | 1.01B | 563.70M | 473.61M | 351.57M | 211.66M | 114.72M | 111.75M |
| Cost of Revenue | 823.56M | 895.85M | 847.96M | 1.10B | 1.12B | 1.07B | 918.00M | 911.08M | 851.88M | 793.97M | 532.63M | 424.32M | 403.79M | 363.09M | 195.39M | 103.98M | 99.87M |
| Gross Profit | 1.69B | 1.14B | 1.26B | 1.16B | 1.19B | 1.28B | 1.35B | 1.22B | 578.95M | 527.52M | 475.41M | 139.39M | 69.82M | -11.51M | 16.27M | 10.74M | 11.88M |
| Gross Profit Ratio | 67.24% | 55.92% | 59.69% | 51.25% | 51.44% | 54.49% | 59.59% | 57.33% | 40.46% | 39.92% | 47.16% | 24.73% | 14.74% | -3.27% | 7.69% | 9.37% | 10.63% |
| Research & Development | 407.01M | 573.32M | 561.86M | 468.90M | 340.94M | 606.56M | 199.91M | 20.74M | 140.46M | 389.83M | 549.62M | 462.25M | 393.50M | 374.70M | 425.24M | 359.52M | 200.54M |
| General & Administrative | 62.97M | 93.64M | 115.87M | 158.11M | 60.75M | 75.11M | 50.91M | 63.79M | 153.76M | 132.36M | 125.06M | 77.40M | 186.42M | 204.18M | 201.02M | 215.12M | 302.95M |
| Selling & Marketing | 992.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.06B | 93.64M | 115.87M | 158.11M | 60.75M | 75.11M | 50.91M | 63.79M | 153.76M | 132.36M | 125.06M | 77.40M | 186.42M | 204.18M | 201.02M | 215.12M | 302.95M |
| Other Expenses | 83.35M | 2.57M | 3.15M | 1.79M | 2.14M | 6.51M | 2.90M | 1.94M | 48.59M | 240.59M | 215.09M | 50.99M | 33.22M | 19.18M | -5.10M | -7.64M | 48.50M |
| Operating Expenses | 1.55B | 1.86B | 1.75B | 1.62B | 1.42B | 1.63B | 1.14B | 911.67M | 1.30B | 1.44B | 1.50B | 1.24B | 974.20M | 918.95M | 921.37M | 933.79M | 885.86M |
| Cost & Expenses | 2.37B | 2.76B | 2.60B | 2.72B | 2.55B | 2.71B | 2.06B | 1.82B | 2.15B | 2.23B | 2.03B | 1.67B | 1.38B | 1.28B | 1.12B | 1.04B | 985.73M |
| Interest Income | 782.00K | 1.14M | 2.40M | 3.04M | 3.48M | 3.88M | 4.91M | 4.85M | 5.71M | 494.00K | 228.00K | 530.00K | 998.00K | 878.00K | 2.21M | 7.90M | 3.29M |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 49.00K | 5.98M | 9.22M | 9.40M | 11.22M | 11.19M | 13.98M | 19.33M | 27.69M | 25.72M | 11.63M | 29.98M |
| Depreciation & Amortization | 134.05M | 131.45M | 124.97M | 102.89M | 124.17M | 119.76M | 122.18M | 122.17M | 136.04M | 86.42M | 88.34M | 86.12M | 95.78M | 106.68M | 114.93M | 102.65M | 105.93M |
| EBITDA | 278.56M | -597.00M | -374.00M | -359.89M | -112.00M | -231.00M | 335.51M | 432.13M | -587.00M | -585.59M | -721.77M | -968.22M | -971.80M | -1.02B | -946.08M | -989.00M | -944.00M |
| EBITDA Ratio | 11.08% | -29.36% | -17.68% | -15.00% | -4.80% | -9.76% | 14.43% | 19.92% | -40.99% | -44.57% | -71.87% | -172.24% | -163.51% | -228.61% | -374.69% | -714.88% | -640.94% |
| Operating Income | 144.51M | -728.12M | -498.18M | -466.86M | -235.18M | -349.75M | 211.51M | 312.39M | -722.60M | -913.10M | -1.03B | -1.10B | -870.16M | -910.40M | -907.98M | -922.79M | -822.20M |
| Operating Income Ratio | 5.75% | -35.82% | -23.68% | -20.68% | -10.18% | -14.83% | 9.31% | 14.63% | -50.50% | -69.10% | -101.73% | -195.68% | -183.73% | -258.95% | -428.98% | -804.35% | -735.73% |
| Total Other Income/Expenses | 2.50M | 2.64M | 4.13M | 4.08M | 5.22M | 9.37M | 2.33M | -2.05M | 44.30M | 1.34M | 201.44M | 29.20M | 14.89M | -222.69M | -190.98M | -207.14M | -208.46M |
| Income Before Tax | 147.01M | -725.48M | -494.05M | -462.78M | -229.78M | -339.63M | 213.33M | 309.95M | -677.70M | -686.69M | -824.00M | -1.07B | -1.09B | -1.15B | -1.10B | -1.13B | -1.08B |
| Income Before Tax Ratio | 5.85% | -35.69% | -23.49% | -20.50% | -9.95% | -14.40% | 9.39% | 14.52% | -47.36% | -51.96% | -81.74% | -190.50% | -230.68% | -328.00% | -517.85% | -985.13% | -968.61% |
| Income Tax Expense | 3.84M | 3.84M | 3.84M | 3.84M | 57.32M | -6.38M | -14.56M | 33.71M | 3.84M | 3.84M | 3.84M | 3.84M | 3.84M | 3.84M | 3.84M | 3.80M | 3.80M |
| Net Income | 143.17M | -729.32M | -497.89M | -466.62M | -287.10M | -333.25M | 227.89M | 276.24M | -681.54M | -690.53M | -827.84M | -1.08B | -1.10B | -1.16B | -1.10B | -1.13B | -1.09B |
| Net Income Ratio | 5.69% | -35.88% | -23.67% | -20.67% | -12.43% | -14.13% | 10.03% | 12.94% | -47.63% | -52.25% | -82.12% | -191.18% | -231.49% | -329.09% | -519.66% | -988.45% | -972.01% |
| EPS | 3.53 | -17.96 | -12.26 | -11.49 | -7.07 | -8.21 | 5.61 | 6.81 | -16.79 | -18.21 | -22.54 | -29.47 | -29.98 | -41.57 | -54.04 | -56.09 | -65.37 |
| EPS Diluted | 3.53 | -17.96 | -12.26 | -11.49 | -7.07 | -8.21 | 5.61 | 6.81 | -16.79 | -18.21 | -22.54 | -29.47 | -29.98 | -41.57 | -54.04 | -56.09 | -65.37 |
| Weighted Avg Shares Out | 40.61M | 40.61M | 40.61M | 40.61M | 40.61M | 40.61M | 40.61M | 40.59M | 40.58M | 37.92M | 36.73M | 36.57M | 36.56M | 27.83M | 20.35M | 20.22M | 16.62M |
| Weighted Avg Shares Out (Dil) | 40.61M | 40.61M | 40.61M | 40.61M | 40.61M | 40.61M | 40.61M | 40.59M | 40.58M | 37.92M | 36.73M | 36.57M | 36.56M | 27.83M | 20.35M | 20.22M | 16.62M |
Source: https://incomestatements.info
Category: Stock Reports